Anikos Laboratories Private Limited
About Anikos Laboratories Private Limited
Data last updated:
Anikos Laboratories Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 20 September 2018.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2018PTC314450. Its GSTIN is 10AARCA3368H1ZP (Bihar).
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It was led by directors Kanchan Kumari and Om Prakash Goswami.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at At. Room No – A – 57 Vijaykant Chawl V M Rd Nehru Ngr Near H P Pump, Mumbai, Maharashtra, India – 400056.
As per the financials filed for FY 2021, the company reported a revenue of ₹18.97 Lakh, a growth of 43% compared to the previous year. For the same year it recorded a net loss of ₹15,106 (net margin -0.8%) and EBITDA of -₹15,106 (EBITDA margin -0.8%).
Company details
Contact details
Anikos Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressAt. Room No – A – 57 Vijaykant Chawl V M Rd Nehru Ngr Near H P Pump, Mumbai, Maharashtra, India – 400056
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Other Chemical Product, Manufacturing
To see the full contact details of Anikos Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Anikos Laboratories is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Anikos Laboratories Private Limited, buy the company report.
Financials of Anikos Laboratories Private Limited
FY 2021 filings availableAnikos Laboratories Private Limited reported revenue of ₹18.97 Lakh (up 43% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue rose 43% in the latest year. EBITDA rose 85% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹15,106 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹15,106 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -0.8% | ||
| Net Profit Margin | -0.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Anikos Laboratories Private Limited, buy the company report.
Board of directors of Anikos Laboratories Private Limited
Anikos Laboratories has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kanchan Kumari Also directs: Goswami and Sons Beverage and Healthcare Private Limited | Director | 21 Apr 2021 | 5 Years 6 Months | As last reported |
| Om Prakash Goswami Also directs: Goswami and Sons Beverage and Healthcare Private Limited | Director | 21 Apr 2021 | 5 Years 6 Months | As last reported |
Peer comparison
Anikos Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dr Tilgam Healthcare (OPC) Private Limited | ₹19.05 Lakh (FY 2025) | Mandla, Madhya Pradesh, India | ||||
| Bionext Healthcare Services Private Limited | ₹19.05 Lakh (FY 2025) | -50.0% | Ambikapur, Chhattisgarh, India | |||
| Nirakaran India Private Limited | ₹19.04 Lakh (FY 2025) | 60.0% | Bhopal, Madhya Pradesh, India | |||
| Wellnfine Private Limited | ₹19.04 Lakh (FY 2024) | -21.0% | Pune, Maharashtra, India | |||
| Das Atmiya Suhrad Foundation | ₹19.01 Lakh (FY 2024) | -68.0% | Anand, Gujarat, India | |||
| Anikos Laboratories Private Limitedthis company | ₹18.97 Lakh (FY 2021) | -₹15,106 | -0.8% | 43.0% | Mumbai, Maharashtra, India | |
| Primax Superspeciality Centre Private Limited | ₹18.96 Lakh (FY 2023) | 301.0% | Gurgaon, Haryana, India | |||
| Vaidher Life Wellness Care Private Limited | ₹18.96 Lakh (FY 2025) | -1.0% | Ernakulam, Kerala, India | |||
| Spam Health Line Homeopathy Par Excellence Private Limited | ₹18.94 Lakh (FY 2020) | 6.0% | New Delhi, Delhi, India | |||
| Zygon Ivf Private Limited | ₹18.92 Lakh (FY 2019) | Ahmedabad, Gujarat, India | ||||
| Medspace Medical Solutions Private Limited | ₹18.9 Lakh (FY 2023) | 8.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Anikos Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Anikos Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anikos Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anikos Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AARCA3368H1ZP | Bihar | Active | 27 Nov 2018 |
To see the full GST registrations and return filing status of Anikos Laboratories Private Limited, buy the company report.
Recent activity
Anikos Laboratories Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Kamal Kishor Singh ceased to be Director on 30 Jul 2021.
Frequently asked questions
Anikos Laboratories has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Anikos Laboratories was a private limited company based in Mumbai, Maharashtra, India. The company worked in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 20 September 2018 and is registered under CIN U24299MH2018PTC314450. The company has been struck off by the Registrar of Companies and is no longer operational.
Anikos Laboratories had 2 directors:
- Kanchan Kumari - Director
- Om Prakash Goswami - Director
The CIN (Corporate Identification Number) of Anikos Laboratories is U24299MH2018PTC314450. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Anikos Laboratories is at At. Room No – A – 57 Vijaykant Chawl V M Rd Nehru Ngr Near H P Pump, Mumbai, Maharashtra, India – 400056.
Anikos Laboratories was incorporated on 20 September 2018. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Anikos Laboratories on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Anikos Laboratories is 10AARCA3368H1ZP, registered in Bihar.
Anikos Laboratories operated in the chemicals industry, in the fine chemicals and other chemical products segment. It worked in this industry before it was struck off.
The peers of Anikos Laboratories by revenue are Dr Tilgam Healthcare (OPC) Private Limited, Bionext Healthcare Services Private Limited, Nirakaran India Private Limited, Wellnfine Private Limited, Das Atmiya Suhrad Foundation and 5 more, all in the same principal business activity (other hospital and medical care activities).
Kamal Kishor Singh ceased to be Director on 30 Jul 2021. Anil Kumar ceased to be Managing Director on 21 Apr 2021. Kanchan Kumari was appointed as Director on 21 Apr 2021. Anikos Laboratories has 4 board changes on record in total.